Epiretinal Membrane Disease

An epiretinal membrane (ERM), also called macular pucker or cellophane maculopathy, is a thin layer of scar-like tissue that forms on the surface of the retina, especially over the macula, which is the part of the retina responsible for sharp central vision. This membrane can contract and gently pull on the retina, causing the picture you see to become blurry, wavy, or distorted. Some people have a very mild ERM and do not notice symptoms; others develop clear vision problems. The condition is most common in older adults and can occur on its own (idiopathic) or after other eye diseases, surgeries, or injuries. NCBIEyeWikiPMCFrontiers

An Epiretinal Membrane (ERM), also called macular pucker, is a thin layer of scar-like tissue that grows on the inner surface of the retina, specifically over the macula—the area responsible for sharp central vision. This membrane can contract, causing the macula to wrinkle or pucker, which distorts vision, blurs details, or produces visual phenomena such as straight lines appearing wavy (metamorphopsia). ERM is most commonly idiopathic (no identifiable cause), but it can also arise secondary to eye surgery, inflammation, retinal tears, or vascular disease. The condition is usually progressive but often mild; many people have ERM and retain acceptable vision without intervention. Diagnosis and management are driven by symptom severity and the effect on daily visual tasks. NCBI Wiley Online Library American Society of Retina Specialists

---

Pathophysiology

ERM forms when cells—mainly glial cells, fibroblasts, and sometimes retinal pigment epithelial cells—migrate to the retinal surface through microscopic defects in the internal limiting membrane. These cells proliferate and lay down extracellular matrix, forming a semitransparent membrane that may contract over time, exerting traction on the underlying retina. Posterior vitreous detachment (PVD), the age-related separation of the vitreous gel from the retina, is the most frequent trigger because it can create microtears or traction that allow cellular migration. Other causes include prior ocular surgery (like cataract extraction), retinal vascular diseases (diabetic retinopathy, vein occlusions), ocular inflammation (uveitis), retinal tears or detachments, and trauma. Increasing age is the strongest risk factor; prevalence rises after age 50. PubMed AAO Journal American Society of Retina Specialists

---

Types of Epiretinal Membrane

1. Idiopathic ERM (primary): This is the most common type. It happens without a known underlying disease. It is usually linked to normal aging changes in the eye where the vitreous gel slowly pulls away from the retina (posterior vitreous detachment), triggering a mild healing response and membrane formation. American Society of Retina SpecialistsPMC

2. Cellophane Macular Reflex: An early form of ERM where the membrane is thin and causes only slight changes in the retina’s appearance. Vision is often near normal, and many people have no symptoms. PMC

3. Macular Pucker / Premacular Fibrosis: A more advanced ERM where the membrane becomes thicker and contracts, causing visual distortion, blurriness, or decreased acuity. This is sometimes described as “puckering” of the macula. PMCPMC

4. Secondary ERM: ERMs that form after or because of a known eye disorder or event. Subtypes include:

   • Post-surgical ERM (e.g., after retinal detachment repair, cataract surgery, vitrectomy). Nature

   • Post-inflammatory ERM from uveitis or other intraocular inflammation. NCBIEyeWiki

   • ERMs after retinal vascular disease such as diabetic retinopathy or retinal vein occlusion. American Society of Retina SpecialistsPMC

   • Trauma-related ERM due to direct injury to the eye. Frontiers

   • ERMs from retinal tears, detachments, or proliferative vitreoretinopathy as part of the healing/fibrotic response. Nature

   • ERMs associated with tumors, radiation, or chronic retinal ischemia where chronic stress or abnormal growth triggers membrane formation. FrontiersNature

5. OCT-based staging/classification: Modern classification often uses optical coherence tomography (OCT) to grade ERMs by severity based on thickness, retinal distortion, and presence of traction. Early stages (mild, with minimal retinal distortion) differ from advanced stages (severe retinal wrinkling and thickening). PMCResearchGate

---

Causes of Epiretinal Membrane

1. Normal aging with posterior vitreous detachment (PVD): The most frequent trigger. As the vitreous pulls away, microscopic breaks or cell migration at the vitreoretinal interface stimulate scar tissue formation. American Society of Retina SpecialistsPMC

2. Idiopathic proliferation: In many older adults, no clear cause is found; glial cells, retinal pigment epithelium cells, or fibroblasts migrate and proliferate on the retinal surface for unclear reasons. EyeWikiFrontiers

3. Diabetic retinopathy: Chronic retinal blood vessel damage and inflammation promote fibrocellular proliferation on the macula surface. American Society of Retina Specialists

4. Retinal vein occlusion: Blocked veins lead to swelling, ischemia, and secondary inflammatory responses that can trigger ERM formation. PMC

5. Retinal tear or detachment (and surgery for it): Tissue injury and healing cascades after detachment or surgical repair can lead to scar tissue on the retinal surface. Nature

6. Cataract or intraocular surgery: Surgery inside the eye can disrupt the normal internal environment, causing inflammation or cell migration that leads to an ERM. Nature

7. Uveitis / intraocular inflammation: Chronic inflammation from diseases like sarcoidosis or autoimmune eye disease makes the retina more likely to develop epiretinal membranes. NCBIEyeWiki

8. Infectious uveitis (e.g., syphilis, tuberculosis, toxoplasmosis, herpes viruses): Infection inside the eye causes inflammation and tissue changes that can result in ERM. canadianjournalofophthalmology.caPMCCleveland Clinic

9. Ocular trauma: Blunt or penetrating injury can disrupt the vitreoretinal interface, starting a scar response. Frontiers

10. Proliferative vitreoretinopathy (PVR): An aggressive scarring process often following retinal detachment, in which cells proliferate abnormally and can produce membranes. Nature

11. Retinal laser photocoagulation: Laser treatment used in diseases like diabetic retinopathy sometimes leads to localized scarring and secondary membrane formation. Nature

12. Radiation retinopathy: Radiation damage causes chronic ischemia and inflammation, which in turn can lead to ERM development. Frontiers

13. Chronic retinal ischemia (e.g., ocular ischemic syndrome): Poor blood flow leads to tissue stress, inflammation, and healing responses. Frontiers

14. Retinal tumors: Tumors like choroidal melanoma change the local retinal environment and can stimulate membrane growth. Frontiers

15. Vitreous hemorrhage: Blood in the vitreous may carry cells that settle on the macula and trigger membrane formation. Frontiers

16. Chronic macular diseases (e.g., age-related macular degeneration with secondary inflammation): Long-standing macular injury or stress may lead to surface proliferation. IOVS

17. Incomplete PVD with persistent traction: Partial detachment leaving tractional forces can stimulate membrane growth. PMCFrontiers

18. Recurrent retinal detachment: Repeated detachment and repair keep activating healing pathways, increasing scar formation chance. Nature

19. Systemic inflammatory disorders affecting the eye: Diseases like sarcoidosis can create ocular inflammation that spreads to the macular surface. PMCEyeWiki

20. Autoimmune eye disease beyond uveitis (e.g., connective tissue disorders): Immune dysregulation can cause low-level inflammation and abnormal repair responses in the retina. NCBI

---

Symptoms of Epiretinal Membrane

1. Blurry central vision: The most common complaint; the center of vision becomes less sharp. PMCPMC

2. Metamorphopsia (distorted vision): Straight lines look wavy or bent, making reading or recognizing faces hard. IOVS

3. Micropsia: Objects appear smaller than they are because the membrane changes how the retina maps images. PMC

4. Aniseikonia: Differences in image size between eyes when only one has the membrane, causing discomfort or double vision. PMC

5. Monocular diplopia (double vision in one eye): The retina sees two slightly offset images from the same object. PMC

6. Difficulty reading small print: Fine details become harder to resolve due to central distortion or reduced acuity. PMCPMC

7. Perception of wavy or warped surfaces: Everyday objects like window blinds or text may look irregular. IOVS

8. Reduced contrast sensitivity: Trouble distinguishing subtle differences in shades or levels of brightness. PMCIOVS

9. Image displacement: Objects might seem shifted or not in their true position. IOVS

10. Visual ghosting or afterimages: Faint secondary images linger because the retinal surface is irregular. PMC

11. Central gray or dark spot (central scotoma): A mild shadow or area of decreased vision in the central field. PMC

12. Eye strain or tiredness: Constant effort to read or focus leads to discomfort. PMC

13. Glare or sensitivity to bright light: Light may flare or scatter more in distorted macular vision. IOVS

14. Difficulty with depth perception: Especially if only one eye is affected, spatial judgment becomes harder. PMC

15. Occasional floaters or flashes: Often due to associated posterior vitreous detachment that may accompany ERM formation. American Society of Retina Specialists

---

Diagnostic Tests

A. Physical Examination

1. Visual Acuity Testing – Measures how clearly a person can see at different distances. Comparing vision in each eye helps quantify central vision loss from ERM. PMCPMC

2. Pupillary Exam (including relative afferent pupillary defect) – Checks for abnormal pupil responses; while ERM usually does not cause a RAPD, this test helps rule out other causes like optic nerve disease. PMCIOVS

3. Intraocular Pressure Measurement – Ensures that elevated pressure or glaucoma is not contributing to vision issues; a baseline is helpful before intervention. American Society of Retina Specialists

4. Dilated Fundus Examination (Slit-lamp with indirect ophthalmoscopy) – The retina specialist uses dilation and a focused light to directly view the macula and see the membrane, retinal puckering, or associated changes. EyeWikiPMC

B. Manual / Functional Tests

5. Amsler Grid – A simple square grid patients use to self-check for metamorphopsia or central distortion, useful for tracking symptom progression. IOVS

6. Contrast Sensitivity Chart – Measures the ability to see differences in shades, which may be reduced even when standard acuity seems okay. IOVS

7. Near Vision Reading Test – Evaluates fine central visual tasks like reading small print, frequently affected early in ERM. PMCPMC

8. Color Vision Testing – While not a primary defect in ERM, subtle changes in color perception or to help rule out other macular diseases may be assessed. IOVS

C. Laboratory and Pathological Tests

9. Syphilis Serology (non-treponemal and treponemal tests) – To detect ocular syphilis, a known infectious cause of uveitis and secondary ERM. canadianjournalofophthalmology.ca

10. Tuberculosis Testing (IGRA or PPD skin test) – Tubercular uveitis can cause retinal inflammation leading to ERM; testing helps evaluate this possibility. PMCEyeWiki

11. Blood Glucose / HbA1c – Diabetes is a major risk factor for retinal disease including ERM via diabetic retinopathy; checking sugar control is part of systemic evaluation. American Society of Retina Specialists

12. Inflammatory / Autoimmune Panel (e.g., ESR, CRP, ANA) – Helps detect underlying inflammatory or autoimmune disorders like sarcoidosis or connective tissue disease contributing to ocular inflammation. PMCNCBI

D. Electrodiagnostic Tests

13. Multifocal Electroretinography (mfERG) – Measures electrical responses from many small areas of the macula to see how the central retina is functioning, helping distinguish ERM effects from other retinal conditions. PMC

14. Full-field Electroretinography (ERG) – Assesses overall retinal function; useful if broader retinal disease is suspected in addition to localized ERM. PMC

15. Visual Evoked Potential (VEP) – Tests how well the visual signals reach the brain; helps rule out optic nerve or pathway problems that might mimic or coexist with ERM symptoms. IOVS

E. Imaging Tests

16. Optical Coherence Tomography (OCT) – The gold standard imaging test for ERM. It gives a detailed cross-sectional picture of the retina, showing the membrane, retinal thickening, distortion, and traction. It can stage the severity. PMCResearchGate

17. Fluorescein Angiography (FA) – A dye-based test that shows blood flow in the retina; helps evaluate associated retinal vascular disease, leakage, or ischemia that may accompany or contribute to ERM. American Society of Retina SpecialistsPMC

18. Fundus Autofluorescence (FAF) – Highlights retinal pigment epithelium changes and chronic stress; can help differentiate ERM changes from other macular disorders. EyeWiki

19. B-scan Ultrasound – Used when the view to the retina is blocked (e.g., due to cataract or hemorrhage) to assess the presence of membranes, vitreous traction, or retinal detachment. Frontiers

20. OCT Angiography (OCTA) – Noninvasive vascular imaging that can show macular perfusion and rule out other causes of visual distortion, aiding in comprehensive evaluation when vascular abnormalities coexist. IOVS

Non-Pharmacological Treatments

1. Observation with regular monitoring: Many mild ERMs cause minimal symptoms and do not progress enough to require treatment. Periodic OCT and vision checks allow watching for worsening. This avoids unnecessary intervention. Medical News Today

2. Low vision rehabilitation: For patients with persistent visual difficulties, specialists offer adaptive strategies such as magnifying devices, high-contrast reading material, and lighting optimization to maximize remaining vision. Rehabilitation improves quality of life without altering the membrane. PubMed

3. Biofeedback training: Visual biofeedback, often using microperimetry, teaches patients to use healthier retinal loci or eccentric viewing to compensate for central distortion. It can improve functional vision even when the ERM remains. PMCPubMed

4. Eccentric viewing training: Patients learn to look slightly away from the distorted center to use less affected retinal areas for reading or detail tasks. This behavioral adaptation can be taught by low vision specialists. PubMed

5. Microperimetry-guided vision exercises: Tailored training based on mapping retinal sensitivity helps focus attention on more functional regions, enhancing visual performance despite structural changes. PubMed

6. Reading aids and assistive technology: Electronic readers, screen magnifiers, text-to-speech software, and adjustable font sizes help bridge deficits in fine central vision. These tools reduce strain and improve function in daily tasks. PubMed

7. Lighting and contrast optimization: Improving ambient lighting, reducing glare, and increasing contrast in workspaces makes it easier to discern details when central vision is compromised. This is a simple environmental adjustment with measurable benefit in function. Wiley Online Library

8. Control of systemic risk factors: Managing systemic diseases like diabetes and hypertension lowers overall ocular stress and prevents concurrent retinal conditions that could compound visual dysfunction. American Society of Retina Specialists

9. Smoking cessation: Tobacco use accelerates oxidative stress and vascular damage in the eye; quitting helps preserve retinal health and reduces risks of other concomitant retinal disease. Verywell Health

10. UV and blue-light protection: Wearing sunglasses that block UV and reducing unnecessary blue light exposure can lower cumulative phototoxic damage to retinal tissues, preserving visual function. retinaeye.com

11. Ergonomic and visual hygiene: Taking regular visual breaks, avoiding prolonged staring at screens without rest, and adjusting screen brightness reduces fatigue and makes compensating for distortion easier. Wiley Online Library

12. Management of dry eye and ocular surface optimization: Clear ocular optics are essential for best possible vision; treating dry eye (artificial tears, eyelid hygiene) reduces fluctuating vision and irritation that can worsen subjective perception of ERM symptoms. Wiley Online Library

13. Patient education and self-monitoring: Teaching patients how to use an Amsler grid at home allows early detection of progression and timely clinical review. Wiley Online Library

14. Psychological support and coping strategies: Sudden or chronic visual distortion can cause anxiety or frustration; counseling and peer support help with adaptation and reduce stress-related amplification of symptoms. (Inference from rehabilitation literature on chronic visual impairment.)

15. Vision staging and goal setting with specialists: Collaborative planning between patient and eye care provider helps prioritize which tasks are affected and set realistic functional goals, improving adherence to compensatory strategies.

16. Use of contrast-enhancing lenses or filters: Special glasses can improve contrast and reduce perceived distortion in some patients, aiding in specific tasks like reading.

17. Avoidance of ocular trauma: Protecting the eye from blows or injury prevents aggravation, especially in eyes with vulnerable retinal architecture.

18. Timely treatment of coexisting cataract: Cataract can worsen perceived visual blurring; appropriately timed cataract surgery can unmask or improve vision, sometimes clarifying the functional impact of ERM. Vitreoretinal Consultants of NY

19. Lifestyle adjustments to reduce visual strain: Breaking tasks into shorter sessions, using voice assistants for heavy visual tasks, and delegating visually intensive activities can reduce functional burden.

20. Regular follow-up imaging (OCT) to guide timing of intervention: Periodic high-resolution structural assessment helps determine if and when surgical membrane removal would offer significant benefit. Wiley Online Library

---

Drug Treatments

Important note: There is no approved medication that reliably dissolves or reverses an established epiretinal membrane itself. Most pharmacological interventions are used either for associated conditions (like macular edema), for managing traction due to vitreomacular adhesion, or experimentally to modulate fibrosis/inflammation. The following are the most relevant agents, some standard and some investigational, with explicit distinctions.

1. Ocriplasmin (microplasmin)

   • Class & Purpose: Proteolytic enzyme used for vitreomacular adhesion (VMA) that can indirectly reduce traction forces contributing to early ERM formation or associated distortion.

   • Dosage/Time: Single intravitreal injection of 0.125 mg.

   • Mechanism: Enzymatically cleaves proteins at the vitreoretinal interface, potentially releasing adhesion and relieving traction.

   • Evidence/Use: Approved for symptomatic VMA; may reduce traction and sometimes delay or alter progression of membrane-related distortion in selected cases.

   • Side Effects: Floaters, transient decrease in visual acuity, dyschromatopsia, eye pain, and rare cases of retinal tears or detachment. AAO Journal

2. Intravitreal Bevacizumab (Avastin)

   • Class & Purpose: Anti-VEGF agent used off-label to treat macular edema from coexisting retinal vascular pathology, not to remove ERM.

   • Dosage/Time: Typical dose 1.25 mg intravitreal injection every 4–6 weeks depending on response.

   • Mechanism: Blocks vascular endothelial growth factor (VEGF), reducing vascular permeability and leakage that contribute to macular thickening.

   • Side Effects: Endophthalmitis (infection), increased intraocular pressure, floaters, and rare thromboembolic events. Wiley Online Library

3. Ranibizumab (Lucentis)

   • Class & Purpose: Anti-VEGF therapy, similar clinical role to bevacizumab in retinal edema from other causes.

   • Dosage/Time: 0.5 mg intravitreal injection monthly or per protocol.

   • Mechanism: VEGF-A inhibition to reduce fluid accumulation and secondary visual distortion.

   • Side Effects: Similar to bevacizumab, including infection risk and eye pressure changes. Wiley Online Library

4. Aflibercept (Eylea)

   • Class & Purpose: Anti-VEGF fusion protein used for retinal vascular leakage.

   • Dosage/Time: 2 mg intravitreal injection, often monthly initially then every 8 weeks in maintenance.

   • Mechanism: Acts as a decoy receptor binding VEGF-A and placental growth factor, reducing edema.

   • Side Effects: Eye pain, cataract progression, endophthalmitis risk. Wiley Online Library

5. Triamcinolone Acetonide Intravitreal Injection

   • Class & Purpose: Corticosteroid for inflammation-driven macular edema that may coexist or worsen visual symptoms in eyes with membrane-related distortion.

   • Dosage/Time: Commonly 4 mg/0.1 mL intravitreal injection, effect lasts several weeks to months.

   • Mechanism: Suppresses inflammatory cytokines, reduces vascular permeability.

   • Side Effects: Elevated intraocular pressure, cataract acceleration, risk of infection. Wiley Online Library

6. Dexamethasone Sustained-Release Implant (Ozurdex)

   • Class & Purpose: Biodegradable corticosteroid implant for diabetic or inflammatory macular edema.

   • Dosage/Time: 0.7 mg implant placed intravitreally; effects last ~3–6 months.

   • Mechanism: Local anti-inflammatory action to decrease swelling.

   • Side Effects: Increased eye pressure, cataract formation. Wiley Online Library

7. Topical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) – e.g., Ketorolac or Bromfenac eye drops

   • Class & Purpose: Reduce perioperative inflammation when planning or recovering from surgical membrane peeling; not curative for ERM.

   • Dosage/Time: Typically applied QID (four times daily) around surgical periods for several days to weeks.

   • Mechanism: Inhibits prostaglandin synthesis, lowering inflammation and potential cystoid macular edema post-op.

   • Side Effects: Rare corneal complications, burning/stinging sensation. Vitreoretinal Consultants of NY

8. Anti-fibrotic Agents (Experimental use such as anti-TGF-beta modulators or CTGF inhibitors)

   • Class & Purpose: Investigational pharmacologic attempts to prevent recurrence of membrane formation by blocking scarring pathways.

   • Dosage/Time: Varies by trial; usually local intraocular delivery in controlled research settings.

   • Mechanism: Interferes with transforming growth factor-beta (TGF-β) signaling or connective tissue growth factor (CTGF) to reduce pathological extracellular matrix deposition.

   • Evidence/Limitations: Early-stage research; not standard-of-care and typically limited to clinical trials. Wiley Online Library

9. Intravitreal siRNA Targeting Fibrosis Pathways (Investigational)

   • Class & Purpose: Gene-silencing therapy to reduce fibrotic membrane progression by blocking specific profibrotic genes.

   • Dosage/Time: Delivered via intraocular injection in trial frameworks.

   • Mechanism: Small interfering RNA (siRNA) downregulates key scarring mediators at mRNA level.

   • Status: Experimental; not yet approved. (Inference from evolving gene therapy approaches in retinal fibrosis research.)

10. Perioperative Adjunctive Steroid Eye Drops (e.g., Prednisolone acetate)

    • Class & Purpose: Reduce inflammation related to surgery that might exacerbate traction or edema.

    • Dosage/Time: Applied postoperatively for variable duration (often tapered over weeks).

    • Mechanism: Topical corticosteroid reduces intraocular inflammation.

    • Side Effects: Elevated intraocular pressure with prolonged use, potential for delayed wound healing.

---

Dietary Molecular Supplements

Although no supplement cures an epiretinal membrane, supporting overall retinal health can reduce additive stress and help maintain the best possible visual function. Many of the following are drawn from large ophthalmic studies (like AREDS/AREDS2) and general retinal nutrition literature.

1. Lutein

   • Dosage: 10 mg daily (as used in AREDS2 and recommended by many eye health authorities).

   • Function: Macular pigment density support; filters blue light and provides antioxidant protection.

   • Mechanism: Accumulates in the macula, scavenges free radicals, and may protect photoreceptors from oxidative damage. mastereyeassociates.comretinaeye.com

2. Zeaxanthin

   • Dosage: 2 mg daily (often combined with lutein).

   • Function: Similar to lutein, contributes to macular pigment and visual performance in glare/contrast conditions.

   • Mechanism: Blue-light filtration and antioxidant. mastereyeassociates.com

3. Vitamin C (Ascorbic Acid)

   • Dosage: 500–1000 mg daily as part of an antioxidant formulation in at-risk individuals.

   • Function: General antioxidant support for ocular tissues.

   • Mechanism: Neutralizes reactive oxygen species and regenerates other antioxidants. NCCIHNCCIH

4. Vitamin E

   • Dosage: 400 IU daily in combination formulas (caution with high doses in certain populations).

   • Function: Protects lipid membranes in retinal cells from oxidative injury.

   • Mechanism: Lipid-soluble antioxidant preventing peroxidation of cell membrane components. NCCIH

5. Zinc (with Copper)

   • Dosage: Zinc oxide 80 mg (elemental zinc ~40 mg) with 2 mg copper to prevent copper deficiency.

   • Function: Enzyme cofactor in antioxidant defense and vitamin A metabolism.

   • Mechanism: Stabilizes cell membranes and supports retinal pigment epithelium health. NCCIH

6. Omega-3 Fatty Acids (EPA/DHA)

   • Dosage: Combined 1000 mg or more daily, depending on formulation.

   • Function: Anti-inflammatory and structural support for retinal photoreceptor membranes.

   • Mechanism: Modulates inflammatory cytokines and integrates into cell membranes enhancing resilience. Verywell Health

7. Copper (as part of AREDS-style mixes)

   • Dosage: 2 mg when high-dose zinc is used.

   • Function: Prevents copper deficiency from high zinc intake and supports enzymatic antioxidant systems.

   • Mechanism: Co-factor for superoxide dismutase and other oxidative stress mediators. NCCIH

8. Alpha-Lipoic Acid

   • Dosage: Often 300–600 mg daily in general antioxidant regimens (though specific ocular dosing varies).

   • Function: Regenerates other antioxidants and reduces oxidative stress systemically.

   • Mechanism: Both water- and lipid-soluble actions help scavenge free radicals and regenerate vitamins C and E. (Extrapolated from antioxidant research for ocular health; direct ERM evidence limited.)

9. N-Acetylcysteine (NAC)

   • Dosage: Common systemic doses range 600–1200 mg daily.

   • Function: Precursor to glutathione, boosting intracellular antioxidant capacity.

   • Mechanism: Increases glutathione synthesis, protecting retinal cells from oxidative challenges. (Inferential application from retinal oxidative stress literature.)

10. Bilberry Extract (Anthocyanins)

    • Dosage: Varies; often 80–160 mg standardized extract daily.

    • Function: Claimed to support microcirculation and provide mild antioxidant effects in the eye.

    • Mechanism: Flavonoids may stabilize capillaries and scavenge free radicals; strong evidence in humans is limited, so use cautiously and in context.

Note: The most rigorously studied combination resembling the above (sans some experimental items) is the AREDS2 formulation, which showed benefit in slowing progression of certain retinal degenerations—though not specifically ERM. Always discuss supplementation with a clinician to avoid interactions or over-supplementation. NCCIHNCCIH

---

Regenerative / Stem Cell / “Hard Immunity” (Investigational) Drugs or Approaches

Currently, therapies aiming to regenerate retinal tissue or modulate scarring in ERM are experimental. None are standard of care for typical ERM, but active research offers future potential. These are described for context, with their intended function, general mechanism, and typical clinical-trial usage:

1. Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium (hESC-RPE) Transplantation

   • Function: Replace or support damaged retinal pigment epithelium to improve retinal environment.

   • Mechanism: Transplanted differentiated RPE cells integrate or support local tissue via trophic factors; delivered subretinally in clinical trials.

   • Status: Phase I/II trials in degenerative diseases demonstrate safety signals, but application for ERM is theoretical and not yet established. PMCBioMed Central

2. Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Progenitor Cells

   • Function: Provide a source of retinal cells to replace damaged neural elements or secrete neuroprotective factors.

   • Mechanism: Patient-specific or donor-derived progenitors are differentiated and injected to promote repair or rescue.

   • Status: Early-stage trials in various retinal dystrophies; relevance to tractional membranes like ERM remains investigational. PMC

3. Mesenchymal Stem Cell (MSC) Intravitreal Injection

   • Function: Paracrine support—anti-inflammatory, anti-fibrotic, and neurotrophic effects to improve retinal health.

   • Mechanism: MSCs secrete cytokines and growth factors that may modulate local inflammation and scarring.

   • Status: Investigated in a range of retinal disorders; rigorous, controlled evidence for ERM is lacking. PMC

4. Encapsulated Cell Technology Delivering Ciliary Neurotrophic Factor (CNTF)

   • Function: Sustained delivery of neurotrophic support to retinal cells.

   • Mechanism: Implantable device releases CNTF to promote cell survival and potentially modulate degenerative changes.

   • Status: Clinical trials in retinal degenerations; its role in preventing or modifying membrane contraction is theoretical. PentaVision

5. Gene Therapy or Small Molecule Modulation of Fibrosis Pathways (e.g., targeting TGF-β / CTGF)

   • Function: Prevent or reduce pathologic membrane formation by interrupting fibrotic signaling.

   • Mechanism: Viral or nonviral delivery of inhibitors, or small molecules, block downstream profibrotic transcription.

   • Status: Research stage with possible future application to ERM recurrence prevention. Wiley Online Library

6. Retinal Cell Transplantation Combined with Scaffold Biomaterials

   • Function: Provide structural support and cell integration in degenerative settings.

   • Mechanism: Cells seeded on biocompatible scaffolds are implanted to promote organized regeneration.

   • Status: Preclinical and early clinical exploration; not yet validated for tractional membrane disease. BioMed Central

Important: These regenerative approaches are not established cures for ERM today; they illustrate directions of research and may become adjunctive or alternative options in the future. PMCPMCPentaVisionBioMed Central

---

Surgeries (Procedures and Why They Are Done)

1. Pars Plana Vitrectomy (PPV) with Epiretinal Membrane Peeling

   • Procedure: A microsurgical procedure where the vitreous gel is removed via small scleral incisions, and the epiretinal membrane is carefully grasped and peeled off the retinal surface using microforceps.

   • Why It Is Done: To relieve the tractional forces distorting the macula, improving visual acuity and reducing metamorphopsia when symptoms are significant. Wiley Online Library

2. Internal Limiting Membrane (ILM) Peeling (Often Combined with ERM Peel)

   • Procedure: After ERM removal, the innermost retina layer (ILM) is also peeled to reduce the risk of membrane recurrence, often using vital dyes for visualization.

   • Why It Is Done: ILM peeling decreases the scaffold for future membrane formation and thus lowers re-proliferation rates. Wiley Online Library

3. Combined Phacovitrectomy (Cataract Surgery + Vitrectomy)

   • Procedure: Concurrent removal of cataractous lens and ERM peeling in one surgical session.

   • Why It Is Done: Many patients with ERM are older and have lens opacities; combining surgeries avoids multiple anesthetic events and addresses overlapping causes of visual decline. Vitreoretinal Consultants of NY

4. Repeat Membrane Peeling for Recurrent ERM

   • Procedure: If ERM recurs and causes renewed visual symptoms, a second vitrectomy/membrane peeling may be performed.

   • Why It Is Done: To restore macular anatomy and patient function when the first surgery’s benefit diminishes due to recurrence. Wiley Online Library

5. Intraoperative Optical Coherence Tomography–Guided Membrane Peeling

   • Procedure: Real-time OCT imaging during surgery helps the surgeon assess completeness of membrane removal and avoid excessive traction.

   • Why It Is Done: Enhances precision, potentially improving outcomes and reducing iatrogenic damage. Wiley Online Library

---

Prevention Strategies

While idiopathic ERM cannot always be prevented, the following strategies reduce risk of secondary membrane formation or limit additive damage:

1. Regular comprehensive eye exams, especially after age 50, to detect early vitreoretinal changes. PubMed

2. Prompt treatment of retinal tears or detachments to avoid secondary scarring and membrane proliferation. Wiley Online Library

3. Control of diabetes and hypertension to prevent microvascular damage that could contribute to retinal stress. American Society of Retina Specialists

4. Avoidance or aggressive management of ocular inflammation (uveitis) to reduce glial proliferation and scarring. Wiley Online Library

5. Safe surgical practices and follow-up after intraocular surgery, minimizing post-op inflammation and preventing complications that can lead to ERM. Vitreoretinal Consultants of NY

6. Smoking cessation to limit oxidative and ischemic stress on retinal tissues. Verywell Health

7. Protecting the eye from trauma that could provoke inflammatory or fibrotic responses.

8. Nutritional support with antioxidants to maintain retinal resilience (e.g., AREDS/AREDS2-type nutrients). NCCIHNCCIH

9. Managing coexisting cataract in a timely fashion to avoid compounding blurred vision and accurately gauge ERM impact. Vitreoretinal Consultants of NY

10. Early evaluation of new visual distortion so interventions (including observation vs surgery) can be appropriately timed and not delayed until irreversible changes. Wiley Online Library

---

When to See a Doctor

You should consult an eye care specialist if you experience any of the following:

• New or worsening central vision blurring that affects reading or recognizing faces. Healthline

• Metamorphopsia, such as straight lines appearing wavy or bent. American Society of Retina Specialists

• A sudden change in vision, even if mild, because it could signal progression or a new associated condition.

• Persistent difficulty with fine detail despite corrective lenses.

• Distorted or double vision in one eye, particularly when it interferes with daily tasks. Wiley Online Library

• Symptoms that are progressive over weeks to months, suggesting increasing membrane traction. PubMed

• If self-monitoring with an Amsler grid shows new areas of distortion or scotoma. Wiley Online Library

• Before planning vision-critical activities (e.g., driving) if vision feels unreliable.

• If previously diagnosed ERM shows functional decline or the patient’s lifestyle is affected enough to consider surgery.

• After other eye diseases or surgeries if new visual symptoms emerge, to distinguish ERM-related change versus other pathology. Vitreoretinal Consultants of NY

---

What to Eat and What to Avoid

What to Eat (foods that support retinal and macular health):

1. Leafy green vegetables (spinach, kale) rich in lutein and zeaxanthin to fortify macular pigment. retinaeye.com

2. Fatty fish (salmon, sardines) for omega-3 fatty acids EPA and DHA, which support anti-inflammatory pathways. Verywell Health

3. Eggs, especially the yolk, which contain lutein, zeaxanthin, and zinc in bioavailable forms. Glamour

4. Citrus fruits (oranges, guava) for vitamin C as an antioxidant. Glamour

5. Nuts and seeds (almonds, walnuts) for vitamin E and healthy fats. Glamour

6. Colorful vegetables (bell peppers, carrots) for broad-spectrum antioxidants including beta-carotene. Glamour

7. Whole grains for maintaining stable blood sugar and supporting vascular health.

8. Lean protein (beans, poultry) providing amino acids for tissue maintenance and repair.

9. Zinc-rich foods (legumes, dairy, meat) to aid in vitamin A transport and retinal enzyme function. Glamour

10. Hydration to support tear film and optimize overall ocular surface clarity.

What to Avoid (foods/lifestyle items that may worsen retinal stress or systemic contributors):

1. High-glycemic-index refined carbohydrates that can spike blood sugar and exacerbate microvascular stress.

2. Excessive saturated and trans fats, which contribute to vascular inflammation.

3. Smoking and tobacco products, directly damaging ocular microcirculation and increasing oxidative stress. Verywell Health

4. Excessive alcohol, which can dehydrate tissues and impair nutrient absorption.

5. High-sodium processed foods, contributing to hypertension and vascular compromise.

6. Sugary beverages and added sugars, which destabilize metabolic control.

7. Overconsumption of vitamin A or unregulated supplements without clinician oversight (since excess can have toxicity).

8. Artificial additives and colorants in large amounts that may cause subtle systemic inflammation in sensitive individuals.

9. Excessive caffeine if it disrupts sleep, indirectly affecting healing and systemic health.

10. Neglecting balanced meals in favor of “fast” convenience foods, which often lack micronutrients vital for eye health.

---

Frequently Asked Questions (FAQs)

1. Can an epiretinal membrane heal on its own?
   Some mild epiretinal membranes remain stable and never progress, so in that sense no active worsening occurs, but the membrane does not truly “disappear” without surgical intervention. Observation is often appropriate when vision is minimally affected. Medical News Today

2. What causes a macular pucker / epiretinal membrane?
   It is most often due to age-related changes like posterior vitreous detachment. Other causes include prior eye surgery, inflammation, retinal tears, and vascular disease. American Society of Retina Specialists

3. Will surgery completely restore my vision?
   Surgery often improves clarity and distortion, but full recovery depends on how long the membrane was present and the degree of underlying retinal distortion. Some residual visual symptoms can persist. Wiley Online Library

4. Is there medicine I can take to dissolve the membrane?
   No currently approved medication reliably dissolves an epiretinal membrane. Some adjacent problems, like associated edema or traction, might be managed with injections or enzymes in select cases. AAO JournalWiley Online Library

5. What are the risks of epiretinal membrane surgery?
   Risks include infection, retinal tear or detachment, cataract progression (if lens is still present), persistent visual distortion, and rarely vision loss. Wiley Online Library

6. Can vision therapy help me if I have ERM but do not want surgery?
   Yes. Low vision rehabilitation, biofeedback, and eccentric viewing training can help maximize functional vision without altering the membrane. PubMed

7. How often should I get checked if I have a mild ERM?
   Follow-up is individualized, but typically every 3–12 months depending on symptoms or OCT changes to monitor progression. Wiley Online Library

8. Does diet make a difference in epiretinal membrane progression?
   While no diet reverses ERM, eating antioxidant-rich foods and controlling systemic diseases helps overall retinal health and may minimize additive damage. NCCIHretinaeye.com

9. Are supplements safe for the eye?
   Supplements like those in the AREDS2 formulation are generally safe when used appropriately, but should be taken under medical guidance, especially if you have other health issues or are a smoker. NCCIHNCCIH

10. What is metamorphopsia and why do I see wavy lines?
    Metamorphopsia is distorted vision where straight lines appear wavy, caused by macular surface distortion from the contracting membrane. American Society of Retina Specialists

11. Can ERM come back after surgery?
    Yes, recurrence can happen, especially if the internal limiting membrane is not peeled. ILM peeling reduces this risk. Wiley Online Library

12. Is the surgery painful?
    Surgery is typically performed under local anesthesia with sedation; patients usually feel minimal discomfort during the procedure and mild irritation afterward. Wiley Online Library

13. Will my peripheral vision be affected by ERM?
    ERM mainly affects central vision and does not typically impact peripheral vision. Wiley Online Library

14. Can both eyes get epiretinal membranes?
    Yes, ERM can affect both eyes, though it often presents asymmetrically. Regular evaluation of both eyes is prudent. PubMed

15. Are there future treatments I should watch for?
    Regenerative medicine including stem cell therapies, anti-fibrotic gene modulation, and improved surgical visualization (like intraoperative OCT) are evolving areas that might offer enhanced outcomes. PMCPMCPentaVisionBioMed Central

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 03, 2025.